一个复杂的FGF14 (TTC) / TGC) 在帕金森病中重复扩张
Xiaosheng Zheng1,2, Zhidong Cen1, Xinhui Chen1
1Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
Movement disorders : official journal of the Movement Disorder Society
|November 24, 2025
概括
在FGF14基因中发现了一种新的复杂重复扩张,被确定为亚洲人群中帕金森病 (PD) 的遗传风险因素. 这一发现凸显了FGF14重复扩张作为PD病变发生的潜在贡献者.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 重复扩张是已知的帕金森病 (PD) 的遗传风险因素.
- 在PD研究中,FGF14-SCA27B (GAA)•(TTC) 重复位,一个新的重复扩张位,仍然未被探索.
- 研究新的遗传位点对于理解PD病因学至关重要.
研究的目的:
- 研究FGF14重复扩张作为亚洲人群中帕金森病 (PD) 的潜在遗传风险因素的作用.
- 描述FGF14重复扩张的序列组成和基因型模式.
- 通过病例控制研究确定FGF14重复扩张和PD风险之间的关联.
主要方法:
- 用基因测序和聚合酶连锁反应 (PCR) 技术检测亚洲PD患者FGF14基因的纯复杂重复扩张.
- 针对性的长读序列被用于分析已识别的重复扩展的详细序列组成.
- 进行了病例控制研究,以评估FGF14重复扩张和PD风险之间的关联.
主要成果:
- 在0.17%的PD患者中发现纯 (TTC) ≥250重复扩张.
- 一个复杂的 (TTC) / (TGC) ≥300重复扩张,有四个不同的细分和基因型模式,被确定为主要的扩展基因型.
- 复杂 (TTC) / TGC) 重复扩张的模式4显示了与对照组相比,PD患者的显著丰富,在发现,复制和元分析队列中得到证实 (P=0.015,OR=1.75).
结论:
- 在FGF14基因中,一个独特的复合体 (TTC) / TGC) 重复扩张代表了亚洲人群中帕金森病 (PD) 的新型遗传风险因素.
- 这一发现扩大了PD已知的遗传景观,并将FGF14与其病变发生相关联.
- 对FGF14重复扩张的进一步研究可能为PD提供新的诊断和治疗途径.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953


